These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8890756)

  • 61. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
    Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
    Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Diagnostic methods and the prognosis of the heart-hypertension interaction: cardiac echo-Doppler].
    Sánchez Domínguez J
    Rev Esp Cardiol; 1995; 48 Suppl 4():49-56. PubMed ID: 7494930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
    Almeida P; Azevedo A; Rodrigues R; Dias P; Friões F; Vazquez B; Abreu-Lima C; Bettencourt P; Barros H
    Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Zinc Levels in Left Ventricular Hypertrophy.
    Huang L; Teng T; Bian B; Yao W; Yu X; Wang Z; Xu Z; Sun Y
    Biol Trace Elem Res; 2017 Mar; 176(1):48-55. PubMed ID: 27452612
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
    Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    Capoulade R; Clavel MA; Dumesnil JG; Chan KL; Teo KK; Tam JW; Côté N; Mathieu P; Després JP; Pibarot P;
    JACC Cardiovasc Imaging; 2013 Feb; 6(2):165-74. PubMed ID: 23489530
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The impact of different left ventricular geometric patterns on right ventricular deformation and function in hypertensive patients.
    Tadic M; Cuspidi C; Vukomanovic V; Kocijancic V; Celic V
    Arch Cardiovasc Dis; 2016 May; 109(5):311-20. PubMed ID: 27020514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control.
    Cuspidi C; Lonati L; Sampieri L; Michev I; Macca G; Rocanova JI; Salerno M; Fusi V; Leonetti G; Zanchetti A
    J Hypertens; 2000 Jun; 18(6):803-9. PubMed ID: 10872567
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
    Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
    Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Left ventricular performance and morphologic myocardial changes in untreated hypertensive patients].
    du Cailar G; Ribstein J; Radauceanu A; Halimi JM; Mimran A
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1011-4. PubMed ID: 7755449
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.
    Sambi RS; Gaur AK; Hotchandani R; Aggarwal KK; Kaur S; Gupta M; Jain S; Krishna CK; Chopra HK; Anand V; Srivastava S; Gupta R; Parashar SK
    Indian Heart J; 2011; 63(3):259-68. PubMed ID: 22734347
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
    Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The degree of albuminuria is related to left ventricular hypertrophy in hypertensive diabetics and is associated with abnormal left ventricular filling: a pilot study.
    Salmasi AM; Jepson E; Grenfell A; Kirollos C; Dancy M
    Angiology; 2003; 54(6):671-8. PubMed ID: 14666955
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical importance of detecting exaggerated blood pressure response to exercise on antihypertensive therapy.
    Mizuno R; Fujimoto S; Saito Y; Yamazaki M
    Heart; 2016 Jun; 102(11):849-54. PubMed ID: 26839069
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
    Cuspidi C; Macca G; Sampieri L; Michev I; Fusi V; Salerno M; Severgnini B; Corti C; Magrini F; Zanchetti A
    J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic immune-inflammation index (SII) may be an effective indicator in predicting the left ventricular hypertrophy for patients diagnosed with hypertension.
    Karayiğit O; Nurkoç SG; Çelik MC
    J Hum Hypertens; 2023 May; 37(5):379-385. PubMed ID: 36175554
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevention and treatment of hypertensive left ventricular hypertrophy.
    Tatavarthy M; Stathopoulos J; Oktay AA
    Curr Opin Cardiol; 2024 Jul; 39(4):251-258. PubMed ID: 38603529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.